PUT/AMGEN/250/0.1/17.01.25 | Market Closed - Börse Stuttgart 05:15:46 2024-07-15 am EDT | ||
| 0.25 EUR | -26.47% |
|
| Current month | -34.21% | ||
| 1 month | -64.79% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-15 | 0.25 | -26.47% |
| 24-07-12 | 0.34 | +3.03% |
| 24-07-11 | 0.33 | -15.38% |
| 24-07-10 | 0.39 | -9.30% |
| 24-07-09 | 0.43 | -2.27% |
Delayed Quote Börse Stuttgart
Last update July 15, 2024 at 05:15 am EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GZ7Z2A |
| ISIN | DE000GZ7Z2A8 |
| Date issued | 2023-01-31 |
| Strike | 250 $ |
| Maturity | 2025-01-17 (186 Days) |
| Parity | 10 : 1 |
| Emission price | 2.57 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.09 € |
|---|---|
| Lowest since issue | 0.25 € |
| Spread | 0.07 € |
| Spread % | 20.00% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
330.2
USD
Average target price
317.4
USD
Spread / Average Target
-3.86%
- Stock Market
- Warrants
- Warrant
